{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:33:48Z","timestamp":1790660028178,"version":"4.1.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"The Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["(2023JJ60101)"],"award-info":[{"award-number":["(2023JJ60101)"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Financial Plan for the High-Level Health Personnel Program of Hunan Province","award":["20230508-1033"],"award-info":[{"award-number":["20230508-1033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1186\/s12014-025-09533-9","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T01:39:05Z","timestamp":1742261945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Plasma proteomics in pediatric patients with sepsis\u2013 hopes and challenges"],"prefix":"10.1186","volume":"22","author":[{"given":"Shiyuan","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saizhen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"9533_CR1","doi-asserted-by":"publisher","unstructured":"Tan B, Wong JJ, Sultana R, et al. Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis. JAMA Pediatr. 2019;173(4):352\u2013362. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.4839","DOI":"10.1001\/jamapediatrics.2018.4839"},{"key":"9533_CR2","doi-asserted-by":"publisher","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. The Lancet. 2020;395(10219):200\u2013211. https:\/\/doi.org\/10.1016\/s0140-6736(19)32989-7","DOI":"10.1016\/s0140-6736(19)32989-7"},{"key":"9533_CR3","doi-asserted-by":"publisher","unstructured":"Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis*. Pediatr Crit Care Med. 2013;14(7):686\u2009\u2212\u200993. https:\/\/doi.org\/10.1097\/PCC.0b013e3182917fad","DOI":"10.1097\/PCC.0b013e3182917fad"},{"key":"9533_CR4","doi-asserted-by":"publisher","unstructured":"Weng L, Zeng XY, Yin P, et al. Sepsis-related mortality in China: a descriptive analysis. Intensive Care Med. 2018;44(7):1071\u20131080. https:\/\/doi.org\/10.1007\/s00134-018-5203-z","DOI":"10.1007\/s00134-018-5203-z"},{"key":"9533_CR5","doi-asserted-by":"publisher","unstructured":"Wang Y, Sun B, Yue H, et al. An epidemiologic survey of pediatric sepsis in regional hospitals in China. Pediatr Crit Care Med. 2014;15(9):814\u2009\u2212\u200920. https:\/\/doi.org\/10.1097\/PCC.0000000000000247","DOI":"10.1097\/PCC.0000000000000247"},{"key":"9533_CR6","doi-asserted-by":"publisher","unstructured":"Xiao C, Wang S, Fang F, et al. Epidemiology of Pediatric Severe Sepsis in Main PICU Centers in Southwest China. Pediatr Crit Care Med. 2019;20(12):1118\u20131125. https:\/\/doi.org\/10.1097\/PCC.0000000000002079","DOI":"10.1097\/PCC.0000000000002079"},{"key":"9533_CR7","doi-asserted-by":"publisher","unstructured":"Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing Sepsis as a Global Health Priority - A WHO Resolution. N Engl J Med. 2017;377(5):414\u2013417. https:\/\/doi.org\/10.1056\/NEJMp1707170","DOI":"10.1056\/NEJMp1707170"},{"key":"9533_CR8","doi-asserted-by":"publisher","unstructured":"Zhou X, Wang Y, Chen J, Pan J. Constructing a 10-core genes panel for diagnosis of pediatric sepsis. J Clin Lab Anal. 2021;35(3):e23680. https:\/\/doi.org\/10.1002\/jcla.23680","DOI":"10.1002\/jcla.23680"},{"key":"9533_CR9","doi-asserted-by":"publisher","unstructured":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89\u201395. https:\/\/doi.org\/10.1067\/mcp.2001.113989","DOI":"10.1067\/mcp.2001.113989"},{"key":"9533_CR10","doi-asserted-by":"publisher","unstructured":"Dalton WS, Friend SH. Cancer Biomarkers; An Invitation to the Table. Science. 2006;312(5777):1165\u20131168. https:\/\/doi.org\/10.1126\/science.1125948","DOI":"10.1126\/science.1125948"},{"key":"9533_CR11","doi-asserted-by":"publisher","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama. 2016;315(8):801\u2009\u2212\u200910. https:\/\/doi.org\/10.1001\/jama.2016.0287","DOI":"10.1001\/jama.2016.0287"},{"key":"9533_CR12","doi-asserted-by":"publisher","unstructured":"Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent JL. Biomarkers of sepsis: time for a reappraisal. Crit Care. 2020;24(1):287. https:\/\/doi.org\/10.1186\/s13054-020-02993-5","DOI":"10.1186\/s13054-020-02993-5"},{"key":"9533_CR13","doi-asserted-by":"publisher","unstructured":"Pierrakos C, Vincent J-L. Sepsis biomarkers: a review. Critical care. 2010;14(1). https:\/\/doi.org\/10.1186\/cc8872","DOI":"10.1186\/cc8872"},{"key":"9533_CR14","doi-asserted-by":"publisher","unstructured":"Ray S, Reddy PJ, Jain R, Gollapalli K, Moiyadi A, Srivastava S. Proteomic technologies for the identification of disease biomarkers in serum: Advances and challenges ahead. Proteomics. 2011;11(11):2139\u20132161. https:\/\/doi.org\/10.1002\/pmic.201000460","DOI":"10.1002\/pmic.201000460"},{"key":"9533_CR15","doi-asserted-by":"publisher","unstructured":"Cao Z, Robinson RA. The role of proteomics in understanding biological mechanisms of sepsis. Proteomics Clin Appl. 2014;8(1\u20132):35\u201352. https:\/\/doi.org\/10.1002\/prca.201300101","DOI":"10.1002\/prca.201300101"},{"key":"9533_CR16","doi-asserted-by":"publisher","unstructured":"Ludwig KR, Hummon AB. Mass spectrometry for the discovery of biomarkers of sepsis. Molecular BioSystems. 2017;13(4):648\u2013664. https:\/\/doi.org\/10.1039\/c6mb00656f","DOI":"10.1039\/c6mb00656f"},{"key":"9533_CR17","doi-asserted-by":"publisher","unstructured":"Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. Journal of leukocyte biology. 2007;81(1):1\u20135. https:\/\/doi.org\/10.1189\/jlb.0306164","DOI":"10.1189\/jlb.0306164"},{"key":"9533_CR18","doi-asserted-by":"publisher","unstructured":"Rajaee A, Barnett R, Cheadle WG. Pathogen- and Danger-Associated Molecular Patterns and the Cytokine Response in Sepsis. Surgical Infections. 2018;19(2):107\u2013116. https:\/\/doi.org\/10.1089\/sur.2017.264","DOI":"10.1089\/sur.2017.264"},{"key":"9533_CR19","doi-asserted-by":"publisher","unstructured":"Fitzgerald KA, Kagan JC. Toll-like Receptors and the Control of Immunity. CELL. 2020;180(6):1044\u20131066. https:\/\/doi.org\/10.1016\/j.cell.2020.02.041","DOI":"10.1016\/j.cell.2020.02.041"},{"key":"9533_CR20","doi-asserted-by":"publisher","unstructured":"Kumar V. Inflammasomes: Pandora&rsquo;s box for sepsis. Journal of Inflammation Research. 2018;Volume 11:477\u2013502. https:\/\/doi.org\/10.2147\/jir.S178084","DOI":"10.2147\/jir.S178084"},{"key":"9533_CR21","doi-asserted-by":"publisher","unstructured":"Karki R, Kanneganti T-D. The \u2018cytokine storm\u2019: molecular mechanisms and therapeutic prospects. Trends in immunology. 2021;42(8):681\u2013705. https:\/\/doi.org\/10.1016\/j.it.2021.06.001","DOI":"10.1016\/j.it.2021.06.001"},{"key":"9533_CR22","doi-asserted-by":"publisher","unstructured":"Moriyama K, Nishida O. Targeting Cytokines, Pathogen-Associated Molecular Patterns, and Damage-Associated Molecular Patterns in Sepsis via Blood Purification. International journal of molecular sciences. 2021;22(16). https:\/\/doi.org\/10.3390\/ijms22168882","DOI":"10.3390\/ijms22168882"},{"key":"9533_CR23","doi-asserted-by":"publisher","unstructured":"Angus DC. The search for effective therapy for sepsis: back to the drawing board? Jama. 2011;306(23):2614-5. https:\/\/doi.org\/10.1001\/jama.2011.1853","DOI":"10.1001\/jama.2011.1853"},{"key":"9533_CR24","doi-asserted-by":"publisher","unstructured":"Dolgin E. Trial failure prompts soul-searching for critical-care specialists. Nature medicine. 2012;18(7):1000\u20131000. https:\/\/doi.org\/10.1038\/nm0712-1000","DOI":"10.1038\/nm0712-1000"},{"key":"9533_CR25","doi-asserted-by":"publisher","unstructured":"Donnelly JP, Hohmann SF, Wang HE. Unplanned Readmissions After Hospitalization for Severe Sepsis at Academic Medical Center\u2013Affiliated Hospitals*. Critical care medicine. 2015;43(9):1916\u20131927. https:\/\/doi.org\/10.1097\/ccm.0000000000001147","DOI":"10.1097\/ccm.0000000000001147"},{"key":"9533_CR26","doi-asserted-by":"publisher","unstructured":"Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G. High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis. 1998;26(5):1076-82. https:\/\/doi.org\/10.1086\/520307","DOI":"10.1086\/520307"},{"key":"9533_CR27","doi-asserted-by":"publisher","unstructured":"Walton AH, Muenzer JT, Rasche D, et al. Reactivation of Multiple Viruses in Patients with Sepsis. PLoS One. 2014;9(6). https:\/\/doi.org\/10.1371\/journal.pone.0098819","DOI":"10.1371\/journal.pone.0098819"},{"key":"9533_CR28","doi-asserted-by":"publisher","unstructured":"Wu H-P, Chung K, Lin C-Y, Jiang B-Y, Chuang D-Y, Liu Y-C. Associations of T helper 1, 2, 17 and regulatory T lymphocytes with mortality in severe sepsis. Inflammation research. 2013;62(8):751\u2013763. https:\/\/doi.org\/10.1007\/s00011-013-0630-3","DOI":"10.1007\/s00011-013-0630-3"},{"key":"9533_CR29","doi-asserted-by":"publisher","unstructured":"Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. Jama. 2011;306(23):2594\u2009\u2212\u2009605. https:\/\/doi.org\/10.1001\/jama.2011.1829","DOI":"10.1001\/jama.2011.1829"},{"key":"9533_CR30","doi-asserted-by":"publisher","unstructured":"Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138\u2009\u2212\u200950. https:\/\/doi.org\/10.1056\/NEJMra021333","DOI":"10.1056\/NEJMra021333"},{"key":"9533_CR31","doi-asserted-by":"publisher","unstructured":"Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nature Reviews Nephrology. 2017;14(2):121\u2013137. https:\/\/doi.org\/10.1038\/nrneph.2017.165","DOI":"10.1038\/nrneph.2017.165"},{"key":"9533_CR32","doi-asserted-by":"publisher","unstructured":"Jensen IJ, Sjaastad FV, Griffith TS, Badovinac VP. Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity. The Journal of Immunology. 2018;200(5):1543\u20131553. https:\/\/doi.org\/10.4049\/jimmunol.1701618","DOI":"10.4049\/jimmunol.1701618"},{"key":"9533_CR33","doi-asserted-by":"publisher","unstructured":"Hotchkiss RS, Swanson PE, Freeman BD, et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med. 1999;27(7):1230-51. https:\/\/doi.org\/10.1097\/00003246-199907000-00002","DOI":"10.1097\/00003246-199907000-00002"},{"key":"9533_CR34","doi-asserted-by":"publisher","unstructured":"Venet F, Boh\u00e9 J, Debard A-L, Bienvenu J, Lepape A, Monneret G. Both percentage of \u03b3\u03b4 T lymphocytes and CD3 expression are reduced during septic shock. Critical care medicine. 2005;33(12):2836\u20132840. https:\/\/doi.org\/10.1097\/01.Ccm.0000189745.66585.Ae","DOI":"10.1097\/01.Ccm.0000189745.66585.Ae"},{"key":"9533_CR35","doi-asserted-by":"publisher","unstructured":"Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature. 1997;390(6658):350-1. https:\/\/doi.org\/10.1038\/37022","DOI":"10.1038\/37022"},{"key":"9533_CR36","doi-asserted-by":"publisher","unstructured":"Tsukamoto H, Kozakai S, Kobayashi Y, et al. Impaired antigen-specific lymphocyte priming in mice after Toll\u2010like receptor 4 activation via induction of monocytic myeloid\u2010derived suppressor cells. European journal of immunology. 2019;49(4):546\u2013563. https:\/\/doi.org\/10.1002\/eji.201847805","DOI":"10.1002\/eji.201847805"},{"key":"9533_CR37","doi-asserted-by":"publisher","unstructured":"Gabrilovich DI. Myeloid-Derived Suppressor Cells. Cancer Immunology Research. 2017;5(1):3\u20138. https:\/\/doi.org\/10.1158\/2326-6066.Cir-16-0297","DOI":"10.1158\/2326-6066.Cir-16-0297"},{"key":"9533_CR38","doi-asserted-by":"publisher","unstructured":"Schrijver IT, Th\u00e9roude C, Roger T. Myeloid-Derived Suppressor Cells in Sepsis. Frontiers in Immunology. 2019;10 https:\/\/doi.org\/10.3389\/fimmu.2019.00327","DOI":"10.3389\/fimmu.2019.00327"},{"key":"9533_CR39","doi-asserted-by":"publisher","unstructured":"Kulkarni U, Herrmenau C, Win SJ, Bauer M, Kamradt T. IL-7 treatment augments and prolongs sepsis-induced expansion of IL-10-producing B lymphocytes and myeloid-derived suppressor cells. PLoS One. 2018;13(2). https:\/\/doi.org\/10.1371\/journal.pone.0192304","DOI":"10.1371\/journal.pone.0192304"},{"key":"9533_CR40","doi-asserted-by":"publisher","unstructured":"Uhel F, Azzaoui I, Gr\u00e9goire M, et al. Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis. Am J Respir Crit Care Med. 2017;196(3):315\u2013327. https:\/\/doi.org\/10.1164\/rccm.201606-1143OC","DOI":"10.1164\/rccm.201606-1143OC"},{"key":"9533_CR41","doi-asserted-by":"publisher","unstructured":"Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med. 2007;35(10):2408-16. https:\/\/doi.org\/10.1097\/01.ccm.0000282072.56245.91","DOI":"10.1097\/01.ccm.0000282072.56245.91"},{"key":"9533_CR42","doi-asserted-by":"publisher","unstructured":"Lindell RB, Zhang D, Bush J, et al. Impaired Lymphocyte Responses in Pediatric Sepsis Vary by Pathogen Type and are Associated with Features of Immunometabolic Dysregulation. Shock. 2022;57(6):191\u2013199. https:\/\/doi.org\/10.1097\/SHK.0000000000001943","DOI":"10.1097\/SHK.0000000000001943"},{"key":"9533_CR43","doi-asserted-by":"publisher","unstructured":"Wang H, Guo C, Wang Y, Li C, Wu Y, Ren X. Immune cell composition and its impact on prognosis in children with sepsis. BMC Pediatrics. 2024;24(1). https:\/\/doi.org\/10.1186\/s12887-024-05087-1","DOI":"10.1186\/s12887-024-05087-1"},{"key":"9533_CR44","doi-asserted-by":"publisher","unstructured":"Ygberg S, Nilsson A. The developing immune system - from foetus to toddler. Acta Paediatr. 2012;101(2):120-7. https:\/\/doi.org\/10.1111\/j.1651-2227.2011.02494.x","DOI":"10.1111\/j.1651-2227.2011.02494.x"},{"key":"9533_CR45","doi-asserted-by":"publisher","unstructured":"Muszynski JA, Nofziger R, Greathouse K, et al. Early adaptive immune suppression in children with septic shock: a prospective observational study. Crit Care. 2014;18(4):R145. https:\/\/doi.org\/10.1186\/cc13980","DOI":"10.1186\/cc13980"},{"key":"9533_CR46","doi-asserted-by":"publisher","unstructured":"Muszynski JA, Nofziger R, Moore-Clingenpeel M, et al. Early Immune Function and Duration of Organ Dysfunction in Critically III Children with Sepsis. Am J Respir Crit Care Med. 2018;198(3):361\u2013369. https:\/\/doi.org\/10.1164\/rccm.201710-2006OC","DOI":"10.1164\/rccm.201710-2006OC"},{"key":"9533_CR47","doi-asserted-by":"publisher","unstructured":"Remy S, Kolev-Descamps K, Gossez M, et al. Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study. Ann Intensive Care. 2018;8(1):36. https:\/\/doi.org\/10.1186\/s13613-018-0382-x","DOI":"10.1186\/s13613-018-0382-x"},{"key":"9533_CR48","doi-asserted-by":"publisher","unstructured":"Carcillo JA, Fields AI. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med. Jun 2002;30(6):1365-78. https:\/\/doi.org\/10.1097\/00003246-200206000-00040","DOI":"10.1097\/00003246-200206000-00040"},{"key":"9533_CR49","doi-asserted-by":"publisher","unstructured":"de Souza DC, Barreira ER, Faria LS. The Epidemiology of Sepsis in Childhood. SHOCK. 2017;47(1S Suppl 1):2\u20135. https:\/\/doi.org\/10.1097\/shk.0000000000000699","DOI":"10.1097\/shk.0000000000000699"},{"key":"9533_CR50","doi-asserted-by":"publisher","unstructured":"Wheeler DS, Wong HR, Zingarelli B. Pediatric Sepsis - Part I: \u201cChildren are not small adults!\u201c. Open Inflamm J. 2011;4:4\u201315. https:\/\/doi.org\/10.2174\/1875041901104010004","DOI":"10.2174\/1875041901104010004"},{"key":"9533_CR51","doi-asserted-by":"publisher","unstructured":"Wheeler DS. Introduction to Pediatric Sepsis. Open Inflamm J. 2011;4(Suppl 1-M):1\u20133. https:\/\/doi.org\/10.2174\/1875041901104010001","DOI":"10.2174\/1875041901104010001"},{"key":"9533_CR52","doi-asserted-by":"crossref","unstructured":"Ceneviva G, Paschall JA, Maffei F, Carcillo JA. Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics. 1998;102(2):e19. 10.1542\/peds.102.2.e19","DOI":"10.1542\/peds.102.2.e19"},{"key":"9533_CR53","doi-asserted-by":"publisher","unstructured":"Luce WA, Hoffman TM, Bauer JA. Bench-to-bedside review: Developmental influences on the mechanisms, treatment and outcomes of cardiovascular dysfunction in neonatal versus adult sepsis. Crit Care. 2007;11(5):228. https:\/\/doi.org\/10.1186\/cc6091","DOI":"10.1186\/cc6091"},{"key":"9533_CR54","doi-asserted-by":"publisher","unstructured":"Emr BM, Alcamo AM, Carcillo JA, Aneja RK, Mollen KP. Pediatric Sepsis Update: How Are Children Different? Surg Infect (Larchmt). 2018;19(2):176\u2013183. https:\/\/doi.org\/10.1089\/sur.2017.316","DOI":"10.1089\/sur.2017.316"},{"key":"9533_CR55","doi-asserted-by":"publisher","unstructured":"Wasinger VC, Cordwell SJ, Cerpa-Poljak A, et al. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis. 1995;16(7):1090-4. https:\/\/doi.org\/10.1002\/elps.11501601185","DOI":"10.1002\/elps.11501601185"},{"key":"9533_CR56","doi-asserted-by":"publisher","unstructured":"Anderson NL, Anderson NG. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis. 1998;19(11):1853-61. https:\/\/doi.org\/10.1002\/elps.1150191103","DOI":"10.1002\/elps.1150191103"},{"key":"9533_CR57","doi-asserted-by":"crossref","unstructured":"Rabilloud T. The Whereabouts of 2D Gels in Quantitative Proteomics. Quantitative Methods in Proteomics. 2012:25\u201335:chap Chap.\u00a02. Methods in Molecular Biology.","DOI":"10.1007\/978-1-61779-885-6_2"},{"key":"9533_CR58","doi-asserted-by":"publisher","unstructured":"Rogowska-Wrzesinska A, Le Bihan M-C, Thaysen-Andersen M, Roepstorff P. 2D gels still have a niche in proteomics. Journal of Proteomics. 2013;88:4\u201313. https:\/\/doi.org\/10.1016\/j.jprot.2013.01.010","DOI":"10.1016\/j.jprot.2013.01.010"},{"key":"9533_CR59","doi-asserted-by":"publisher","unstructured":"Hamon MP, Ahmed EK, Baraibar MA, Friguet B. Proteome Oxidative Modifications and Impairment of Specific Metabolic Pathways During Cellular Senescence and Aging. Proteomics. 2020;20(5\u20136):e1800421. https:\/\/doi.org\/10.1002\/pmic.201800421","DOI":"10.1002\/pmic.201800421"},{"key":"9533_CR60","doi-asserted-by":"publisher","unstructured":"Yu Q, Zhong X, Chen B, et al. Isobaric Labeling Strategy Utilizing 4-Plex N,N-Dimethyl Leucine (DiLeu) Tags Reveals Proteomic Changes Induced by Chemotherapy in Cerebrospinal Fluid of Children with B-Cell Acute Lymphoblastic Leukemia. J Proteome Res. 2020;19(7):2606\u20132616. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00291","DOI":"10.1021\/acs.jproteome.0c00291"},{"key":"9533_CR61","doi-asserted-by":"publisher","unstructured":"Marcus K, Lelong C, Rabilloud T. What Room for Two-Dimensional Gel-Based Proteomics in a Shotgun Proteomics World? Proteomes. 2020;8(3). https:\/\/doi.org\/10.3390\/proteomes8030017","DOI":"10.3390\/proteomes8030017"},{"key":"9533_CR62","doi-asserted-by":"publisher","unstructured":"Dhillon HS, Johnson G, Shannon M, Greenwood C, Roberts D, Bustin S. Homogeneous and digital proximity ligation assays for the detection of Clostridium difficile toxins A and B. Biomol Detect Quantif. 2016;10:2\u20138. https:\/\/doi.org\/10.1016\/j.bdq.2016.06.003","DOI":"10.1016\/j.bdq.2016.06.003"},{"key":"9533_CR63","doi-asserted-by":"publisher","unstructured":"Joshi A, Mayr M. In Aptamers They Trust: The Caveats of the SOMAscan Biomarker Discovery Platform from SomaLogic. Circulation. 2018;138(22):2482\u20132485. https:\/\/doi.org\/10.1161\/circulationaha.118.036823","DOI":"10.1161\/circulationaha.118.036823"},{"key":"9533_CR64","doi-asserted-by":"publisher","unstructured":"Kondori N, Kurtovic A, Pineiro-Iglesias B, et al. Mass Spectrometry Proteotyping-Based Detection and Identification of Staphylococcus aureus, Escherichia coli, and Candida albicans in Blood. Front Cell Infect Microbiol. 2021;11:634215. https:\/\/doi.org\/10.3389\/fcimb.2021.634215","DOI":"10.3389\/fcimb.2021.634215"},{"key":"9533_CR65","doi-asserted-by":"publisher","unstructured":"Mu A, Klare WP, Baines SL, et al. Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria. Nature Communications. 2023;14(1). https:\/\/doi.org\/10.1038\/s41467-023-37200-w","DOI":"10.1038\/s41467-023-37200-w"},{"key":"9533_CR66","doi-asserted-by":"publisher","unstructured":"de Azambuja Rodrigues PM, Valente RH, Brunoro GVF, et al. Proteomics reveals disturbances in the immune response and energy metabolism of monocytes from patients with septic shock. Sci Rep. 2021;11(1):15149. https:\/\/doi.org\/10.1038\/s41598-021-94474-0","DOI":"10.1038\/s41598-021-94474-0"},{"key":"9533_CR67","doi-asserted-by":"publisher","unstructured":"Jarczak D, Kluge S, Nierhaus A. Sepsis-Pathophysiology and Therapeutic Concepts. Front Med (Lausanne). 2021;8:628302. https:\/\/doi.org\/10.3389\/fmed.2021.628302","DOI":"10.3389\/fmed.2021.628302"},{"key":"9533_CR68","doi-asserted-by":"publisher","unstructured":"Mi Y, Burnham KL, Charles PD, et al. High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient response. Sci Transl Med. 2024;16(750):eadh0185. https:\/\/doi.org\/10.1126\/scitranslmed.adh0185","DOI":"10.1126\/scitranslmed.adh0185"},{"key":"9533_CR69","doi-asserted-by":"publisher","unstructured":"Palmowski L, Weber M, Bayer M, et al. Mortality-associated plasma proteome dynamics in a prospective multicentre sepsis cohort. EBioMedicine. 2025;111. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105508","DOI":"10.1016\/j.ebiom.2024.105508"},{"key":"9533_CR70","doi-asserted-by":"publisher","unstructured":"Wong HR. Sepsis Biomarkers. J Pediatr Intensive Care. 2019;8(1):11\u201316. https:\/\/doi.org\/10.1055\/s-0038-1677537","DOI":"10.1055\/s-0038-1677537"},{"key":"9533_CR71","doi-asserted-by":"publisher","unstructured":"Marx D, Metzger J, Pejchinovski M, et al. Proteomics and Metabolomics for AKI Diagnosis. Semin Nephrol. 2018;38(1):63\u201387. https:\/\/doi.org\/10.1016\/j.semnephrol.2017.09.007","DOI":"10.1016\/j.semnephrol.2017.09.007"},{"key":"9533_CR72","doi-asserted-by":"publisher","unstructured":"Wang Y, Fan Y, Jiang Y, et al. APOA2: New Target for Molecular Hydrogen Therapy in Sepsis-Related Lung Injury Based on Proteomic and Genomic Analysis. International journal of molecular sciences. 2023;24(14). https:\/\/doi.org\/10.3390\/ijms241411325","DOI":"10.3390\/ijms241411325"},{"key":"9533_CR73","doi-asserted-by":"publisher","unstructured":"Liang X, Wu T, Chen Q, et al. Serum proteomics reveals disorder of lipoprotein metabolism in sepsis. Life Sci Alliance. 2021;4(10). https:\/\/doi.org\/10.26508\/lsa.202101091","DOI":"10.26508\/lsa.202101091"},{"key":"9533_CR74","doi-asserted-by":"publisher","unstructured":"Thongboonkerd V, Chiangjong W, Mares J, et al. Altered plasma proteome during an early phase of peritonitis-induced sepsis. Clin Sci (Lond). 2009;116(9):721\u2009\u2212\u200930. https:\/\/doi.org\/10.1042\/CS20080478","DOI":"10.1042\/CS20080478"},{"key":"9533_CR75","doi-asserted-by":"publisher","unstructured":"Ruiz-Sanmartin A, Ribas V, Sunol D, et al. Characterization of a proteomic profile associated with organ dysfunction and mortality of sepsis and septic shock. PLoS One. 2022;17(12):e0278708. https:\/\/doi.org\/10.1371\/journal.pone.0278708","DOI":"10.1371\/journal.pone.0278708"},{"key":"9533_CR76","doi-asserted-by":"publisher","unstructured":"Kapp KL, Arul AB, Zhang KC, et al. Proteomic changes associated with racial background and sepsis survival outcomes. Mol Omics. 2022;18(10):923\u2013937. https:\/\/doi.org\/10.1039\/d2mo00171c","DOI":"10.1039\/d2mo00171c"},{"key":"9533_CR77","doi-asserted-by":"publisher","unstructured":"Rovas A, Buscher K, Osiaevi I, et al. Microvascular and proteomic signatures overlap in COVID-19 and bacterial sepsis: the Microcode study. Angiogenesis. 2022;25(4):503\u2013515. https:\/\/doi.org\/10.1007\/s10456-022-09843-8","DOI":"10.1007\/s10456-022-09843-8"},{"key":"9533_CR78","doi-asserted-by":"publisher","unstructured":"Han M, Fitzgerald JC, Balamuth F, et al. Association of Delayed Antimicrobial Therapy with One-Year Mortality in Pediatric Sepsis. Shock. 2017;48(1):29\u201335. https:\/\/doi.org\/10.1097\/SHK.0000000000000833","DOI":"10.1097\/SHK.0000000000000833"},{"key":"9533_CR79","doi-asserted-by":"publisher","unstructured":"Kacar AG, Celkan TT. Hemophagocytic Lymphohistiocytosis. Balkan Med J. 2022;39(5):309\u2013317. https:\/\/doi.org\/10.4274\/balkanmedj.galenos.2022.2022-4-83","DOI":"10.4274\/balkanmedj.galenos.2022.2022-4-83"},{"key":"9533_CR80","doi-asserted-by":"publisher","unstructured":"Lin H, Scull BP, Goldberg BR, et al. IFN-gamma signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS. Blood Adv. 2021;5(17):3457\u20133467. https:\/\/doi.org\/10.1182\/bloodadvances.2021004287","DOI":"10.1182\/bloodadvances.2021004287"},{"key":"9533_CR81","doi-asserted-by":"publisher","unstructured":"Shubin NJ, Navalkar K, Sampson D, et al. Serum Protein Changes in Pediatric Sepsis Patients Identified With an Aptamer-Based Multiplexed Proteomic Approach. Crit Care Med. 2020;48(1):e48-e57. https:\/\/doi.org\/10.1097\/CCM.0000000000004083","DOI":"10.1097\/CCM.0000000000004083"},{"key":"9533_CR82","doi-asserted-by":"publisher","unstructured":"Palma Medina LM, Baba\u010di\u0107 H, Dzidic M, et al. Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia. Respiratory research. 2023;24(1). https:\/\/doi.org\/10.1186\/s12931-023-02364-y","DOI":"10.1186\/s12931-023-02364-y"},{"key":"9533_CR83","doi-asserted-by":"publisher","unstructured":"Buhimschi CS, Bhandari V, Han YW, et al. Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future. Curr Opin Infect Dis. 2009;22(3):235\u2009\u2212\u200943. https:\/\/doi.org\/10.1097\/QCO.0b013e32832a5963","DOI":"10.1097\/QCO.0b013e32832a5963"},{"key":"9533_CR84","doi-asserted-by":"publisher","unstructured":"McCafferty C, Chaaban J, Ignjatovic V. Plasma proteomics and the paediatric patient. Expert Review of Proteomics. 2019;16(5):401\u2013411. https:\/\/doi.org\/10.1080\/14789450.2019.1608186","DOI":"10.1080\/14789450.2019.1608186"},{"key":"9533_CR85","doi-asserted-by":"publisher","unstructured":"Karasawa R, Tamaki M, Sato T, et al. Multiple target autoantigens on endothelial cells identified in juvenile dermatomyositis using proteomics. Rheumatology. 2018;57(4):671\u2013676. https:\/\/doi.org\/10.1093\/rheumatology\/kex468","DOI":"10.1093\/rheumatology\/kex468"},{"key":"9533_CR86","doi-asserted-by":"publisher","unstructured":"Liu C-W, Bramer L, Webb-Robertson B-J, Waugh K, Rewers MJ, Zhang Q. Temporal expression profiling of plasma proteins reveals oxidative stress in early stages of Type 1 Diabetes progression. Journal of Proteomics. 2018;172:100\u2013110. https:\/\/doi.org\/10.1016\/j.jprot.2017.10.004","DOI":"10.1016\/j.jprot.2017.10.004"},{"key":"9533_CR87","doi-asserted-by":"publisher","unstructured":"Zohaib M, Ansari SH, Shamsi TS, Zubarev RA, Zarina S. Pharmacoproteomics Profiling of Plasma From \u03b2-Thalassemia Patients in Response to Hydroxyurea Treatment. The Journal of Clinical Pharmacology. 2018;59(1):98\u2013106. https:\/\/doi.org\/10.1002\/jcph.1297","DOI":"10.1002\/jcph.1297"},{"key":"9533_CR88","doi-asserted-by":"publisher","unstructured":"Repetto O, Mussolin L, Elia C, et al. Proteomic Identification of Plasma Biomarkers in Children and Adolescents with Recurrent Hodgkin Lymphoma. Journal of Cancer. 2018;9(24):4650\u20134658. https:\/\/doi.org\/10.7150\/jca.27560","DOI":"10.7150\/jca.27560"},{"key":"9533_CR89","doi-asserted-by":"publisher","unstructured":"Li J, Sun L, Xu F, et al. Screening and Identification of APOC1 as a Novel Potential Biomarker for Differentiate of Mycoplasma pneumoniae in Children. Frontiers in Microbiology. 2016;7. https:\/\/doi.org\/10.3389\/fmicb.2016.01961","DOI":"10.3389\/fmicb.2016.01961"},{"key":"9533_CR90","doi-asserted-by":"publisher","unstructured":"Chatziioannou AC, Wolters JC, Sarafidis K, et al. Targeted LC-MS\/MS for the evaluation of proteomics biomarkers in the blood of neonates with necrotizing enterocolitis and late-onset sepsis. Analytical and bioanalytical chemistry. 2018;410(27):7163\u20137175. https:\/\/doi.org\/10.1007\/s00216-018-1320-3","DOI":"10.1007\/s00216-018-1320-3"},{"key":"9533_CR91","doi-asserted-by":"publisher","unstructured":"Davis MT, Beierle J, Bures ET, et al. Automated LC-LC-MS-MS platform using binary ion-exchange and gradient reversed-phase chromatography for improved proteomic analyses. J Chromatogr B Biomed Sci Appl. 2001;752(2):281\u2009\u2212\u200991. https:\/\/doi.org\/10.1016\/s0378-4347(00)00547-8","DOI":"10.1016\/s0378-4347(00)00547-8"},{"key":"9533_CR92","doi-asserted-by":"publisher","unstructured":"Vissers JP, Blackburn RK, Moseley MA. A novel interface for variable flow nanoscale LC\/MS\/MS for improved proteome coverage. J Am Soc Mass Spectrom. 2002;13(7):760\u2009\u2212\u200971. https:\/\/doi.org\/10.1016\/s1044-0305(02)00418-x","DOI":"10.1016\/s1044-0305(02)00418-x"},{"key":"9533_CR93","doi-asserted-by":"publisher","unstructured":"Liu X, Ren H, Peng D. Sepsis biomarkers: an omics perspective. Front Med.2014;8(1):58\u201367. https:\/\/doi.org\/10.1007\/s11684-014-0318-2","DOI":"10.1007\/s11684-014-0318-2"},{"key":"9533_CR94","doi-asserted-by":"publisher","unstructured":"Deutsch EW, Omenn GS, Sun Z, et al. Advances and Utility of the Human Plasma Proteome. J Proteome Res. 2021;20(12):5241\u20135263. https:\/\/doi.org\/10.1021\/acs.jproteome.1c00657","DOI":"10.1021\/acs.jproteome.1c00657"},{"key":"9533_CR95","doi-asserted-by":"publisher","unstructured":"Ignjatovic V, Geyer PE, Palaniappan KK, et al. Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data. Journal of proteome research. 2019;18(12):4085\u20134097. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00503","DOI":"10.1021\/acs.jproteome.9b00503"},{"key":"9533_CR96","doi-asserted-by":"publisher","unstructured":"Qian W-J, Jacobs JM, Liu T, Camp DG, Smith RD. Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications. MOlecular & cellular proteomics. 2006;5(10):1727\u20131744. https:\/\/doi.org\/10.1074\/mcp.M600162-MCP200","DOI":"10.1074\/mcp.M600162-MCP200"},{"key":"9533_CR97","doi-asserted-by":"publisher","unstructured":"Herzog CMS, Goeminne LJE, Poganik JR, et al. Challenges and recommendations for the translation of biomarkers of aging. Nature Aging. 2024;4(10):1372\u20131383. https:\/\/doi.org\/10.1038\/s43587-024-00683-3","DOI":"10.1038\/s43587-024-00683-3"},{"key":"9533_CR98","doi-asserted-by":"publisher","unstructured":"Wang X, Ward PA. Opportunities and challenges of disease biomarkers: a new section in the Journal of Translational Medicine. J Transl Med. 2012;10:240. https:\/\/doi.org\/10.1186\/1479-5876-10-240","DOI":"10.1186\/1479-5876-10-240"},{"key":"9533_CR99","doi-asserted-by":"publisher","unstructured":"Bravo-Merodio L, Williams JA, Gkoutos GV, Acharjee A. -Omics biomarker identification pipeline for translational medicine. Journal of Translational Medicine. 2019;17(1). https:\/\/doi.org\/10.1186\/s12967-019-1912-5","DOI":"10.1186\/s12967-019-1912-5"},{"key":"9533_CR100","doi-asserted-by":"publisher","unstructured":"Hartung T, King NMP, Kleinstreuer N, Leist M, Tagle DA. Leveraging biomarkers and translational medicine for preclinical safety - Lessons for advancing the validation of alternatives to animal testing. Altex. 2024;41(4):545\u2013566. https:\/\/doi.org\/10.14573\/altex.2410011","DOI":"10.14573\/altex.2410011"},{"key":"9533_CR101","doi-asserted-by":"publisher","unstructured":"Hartl D, de Luca V, Kostikova A, et al. Translational precision medicine: an industry perspective. Journal of Translational Medicine. 2021;19(1). https:\/\/doi.org\/10.1186\/s12967-021-02910-6","DOI":"10.1186\/s12967-021-02910-6"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-025-09533-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-025-09533-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-025-09533-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T01:39:15Z","timestamp":1742261955000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-025-09533-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9533"],"URL":"https:\/\/doi.org\/10.1186\/s12014-025-09533-9","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}